PATENT CLAIM ANALYSIS

Application Number: 15771550
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "224500"]

Abstract:
The present invention relates to small molecule compounds based on benzopyrimido- or benzoimidazo-thiazin-imine as well as their (synthesis) intermediates and their use as HDAC inhibitors, in particular HDAC8 inhibitors. The present invention also relates to the use of said compounds in the treatment of cancer and as therapeutic agents for eukaryotic parasites and respective methods of treatment.

Claim (Index 25):
The method, according to  claim 22 , wherein 2; R 3 , R 4 , and R 6  are each hydrogen; and R 5  is Br.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.47619
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11687565', '12988271', '13897582', '13683880', '13821190']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7809026752465095
- 35 USC 102 Novelty (BERT): 0.5392658410940484
- Combined Prediction Score: 0.7567389918312634
- Mean Citation Score: 341.70378
- Max Citation Score: 360.39923
- Similarity Product: 265.3827226040441

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test